EDITOR'S COMMENT

International Braz J Urol Oxidative Stress and Sperm Chromatin Damage in Male Infertility
The September -October 2007 issue of the International Braz J Urol presents interesting contributions, and as usual, the editor's comment highlights some papers. Doctor Cocuzza and collaborators, from the Reproductive Research Center, Cleveland Clinic, Ohio, and Tulane University Health Sciences Center, New Orleans, Louisiana, USA presented on page 603 an important review article on the clinical relevance of oxidative stress and sperm chromatin damage in male infertility. The authors demonstrated that despite the controversial findings in the existing literature, there is now enough evidence to show that sperm DNA damage is detrimental to reproductive outcomes. In addition, spermatozoa of infertile men are suggested to carry more DNA damage than do the spermatozoa from fertile men. Besides impairment of fertility such damage is likely to increase the transmission of genetic diseases during the assisted reproductive procedures. Standardization of protocols to assess reactive oxygen species (ROS) and DNA damage is very important in introducing these tests in such clinical practice. Thus evaluation of seminal ROS levels and extent of sperm DNA damage especially in an infertile male may help develop new therapeutic strategies and improve success of assisted reproductive techniques. Doctor Mota and co-workers, from the Federal University of Ceara and University of Sao Paulo Ribeirao Preto, Sao Paulo, Brazil, investigate on page 704 the possible protective effect of recombinant human interleukin-11 (rhIL-11) against ifosfamide (IFS)-induced hemorrhagic cystitis (HC). They studied male Swiss mice pretreated with rhIL-11 (25-625 µg, subcutaneously.) 30 min before intraperitoneal injection of IFS (400 mg/kg) or with saline (control group). Twelve hours later, HC was evaluated by bladder wet weight (BWW) to quantify edema, Evans blue extravasation (EBE) to measure vascular permeability, and macroscopic and microscopic analysis. All bladders were assessed by histopathological analysis. rhIL-11 (at 125 and 625 µg) attenuated the IFS-induced increase of BWW (37.48% and 45.44%, respectively, p < 0.05) and EBE (62.35% and 56.47%, respectively, p < 0.05). The results demonstrate a protective effect of rhIL-11 on experimental IFS-induced HC, which were not previously reported. Doctor Picolli and colleagues, from the Section of Nephrology, Federal University of Sao Paulo, UNIFESP, Sao Paulo, Brazil investigates on page 622 the association between matrix metalloproteinase-1 (MMP-1) promoter polymorphism and risk of renal cell carcinoma. The authors genotyped 217 individuals, 99 patients with renal cell carcinoma (RCC) and 118 controls without cancer. DNA specimens were extracted from epithelial buccal cells and paraffin-embedded tissue of RCC patients and from epithelial buccal cells and blood cells of healthy controls. The comparison of genotype distribution and frequency of 2G allele in different populations showed a strong variability of 2G allele frequency among the different ethnic groups. This fact may influence on the collaboration of this 2G allele in RCC or others diseases. The data suggested
